Sort
1,049,261 grants matching “t cell”
LSC: Bloomington Drosophila Stock Center at Indiana University
$3,324,349Kathleen A Matthews · Indiana University · · FY2009 · BIO
Stanford Cancer Institute
$3,324,271Steven E Artandi · Stanford University · P30 · FY2019 · CA
IGERT- Nanomedical Science and Technology
$3,323,891Srinivas Sridhar · Northeastern University · · FY2005 · EDU
Investigating aberrant vesicular degradation and lipid metabolism in neurodegeneration
$3,323,710Daryl A Bosco · Univ Of Massachusetts Med Sch Worcester · RF1 · FY2025 · NS
Developing Inhibitors of Seasonal and Pandemic Influenza Viruses
$3,323,410Richard K. Plemper · Georgia State University · R01 · FY2025 · AI
Framingham Project/Levy
$3,323,367Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
HEAL Clinical Coordinating Resource Center for the Pain Management Effectiveness Research Network
$3,323,278Daniel K Benjamin · Duke University · U24 · FY2024 · TR
Immunometabolic phenotypes in adult severe asthma and disease progression
$3,322,614Bruce D Levy · Brigham And Women'S Hospital · U01 · FY2022 · HL
THIS PROJECT AIMS TO DEMONSTRATE A GROUNDBREAKING CAUSTIC AQUEOUS PHASE REFORMING (C-APR) TECHNOLOGY TO PRODUCE CARBON-NEGATIVE, CLEAN HYDROGEN (H2) FROM RAW BIOETHANOL. BIOETHANOL, A WIDELY DISTRIBUTED FEEDSTOCK IN THE U.S., IS A KEY COMPONENT DUE TO ITS BROAD AVAILABILITY AND THE U.S.'S STATUS AS A LEADING PRODUCER. THE C-APR TECHNOLOGY ENABLES CLEAN H2 PRODUCTION AT OR BELOW $3/KG, WHICH WILL POWER HIGH-TEMPERATURE FUEL CELLS FOR GRID-FREE ELECTRIC VEHICLE (EV) CHARGING STATIONS. THESE STATIONS OFFER A SUSTAINABLE, VERSATILE SOLUTION TO SUPPORT THE U.S.'S GROWING EV FLEET WHILE MINIMIZING IMPACT ON AN ALREADY STRAINED ELECTRIC GRID. THE C-APR SYSTEM GENERATES HIGHLY PURE H2 (= 99%) AT TEMPERATURES BELOW 250°C AND PRESSURES UNDER 40 BAR, WITHOUT THE NEED FOR MEMBRANES OR OTHER CO2 SEPARATION TECHNOLOGIES THAT WOULD OTHERWISE SIGNIFICANTLY INCREASE ITS OPERATIONAL COST. FOR OUR C-APR TECHNOLOGY, CO2 FROM BIOETHANOL IS CONVERTED IN SITU INTO LIQUID BICARBONATE USING CAUSTIC CHEMISTRY, ALLOWING FURTHER TRANSFORMATION INTO VALUE-ADDED CARBON PRODUCTS, THUS ACHIEVING CARBON-NEGATIVE H2 PRODUCTION. BY UTILIZING WASTE HEAT TO SUSTAIN THE C-APR PROCESS, THE SYSTEM EFFICIENTLY SUPPORTS ITS OWN STEADY-STATE OPERATION. ALIGNED WITH ARPA-E’S MISSION, THE PROPOSED TECHNOLOGY PROMISES ECONOMIC, ENVIRONMENTAL, AND ENERGY SECURITY BENEFITS BY REDUCING DEPENDENCE ON FOREIGN ENERGY AND LOWERING NET GREENHOUSE GAS EMISSIONS.
$3,322,415Washington State University · · FY2025 · Department of Energy
Data and Statistical Coordinating Center (DSCC) for the Collaborative Islet Trans
$3,321,772Franca B Barton · The Emmes Company, Llc · UC4 · FY2012 · DK
Structural Biology of Genome Maintenance and DNA repair
$3,320,685Scott Williams · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Transcription Network Controlling Drosophila Development
$3,320,162University Of Calif-Lawrenc Berkeley Lab · R01 · FY2003 · GM
Transgenic Resources for Neuroscience Research
$3,319,825James Pickel · National Institute Of Mental Health · ZIC · FY2017 · MH
South Dakota Biomedical Research Infrastructure Network
$3,319,582Victor Chester Huber · University Of South Dakota · P20 · FY2022 · GM
The UCSC Genome Browser
$3,319,193Maximilian Haeussler · University Of California Santa Cruz · U24 · FY2024 · HG
The UCSC Genome Browser
$3,319,192Maximilian Haeussler · University Of California Santa Cruz · U24 · FY2025 · HG
Integrative genetics of behavior with high throughput technologies
$3,319,050David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA
Alzheimer's Disease Research Center
$3,318,934Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2020 · AG
Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells
$3,318,209Trevor K Archer · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Joint Center for Mendelian Genomics
$3,317,585Daniel G Macarthur · Broad Institute, Inc. · UM1 · FY2018 · HG
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
$3,317,479Kenneth E Palmer · University Of Louisville · U19 · FY2015 · AI
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
$3,316,841Elizabeth Phillips · Vanderbilt University Medical Center · U01 · FY2022 · AI
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas
$3,316,818Margaret A Shipp · Dana-Farber Cancer Inst · P01 · FY2009 · CA
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$3,316,612Barry Coller · Rockefeller University · UL1 · FY2010 · RR
DNA Sequencing Core
$3,316,179Yue-Sheng Li · National Heart, Lung, And Blood Institute · ZIC · FY2023 · HL